Amonafide salts

Details for Australian Patent Application No. 2003221771 (hide)

International Classifications

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 10/128,129 22.04.02 US

11 December 2003 Application Open to Public Inspection

Published as AU-B-2003221771

15 February 2007 Application Accepted

Published as AU-B-2003221771

14 June 2007 Standard Patent Sealed

2 August 2007 Assignment Registered

Xanthus Life Sciences, Inc. The patent has been assigned to Xanthus Pharmaceuticals, Inc.

24 March 2011 Assignment Registered

Xanthus Pharmaceuticals, Inc. The patent has been assigned to Antisoma Research Limited

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.